Press release
Next Generation Sequencing (NGS) Market Size, Share, Trends, Industry Analysis, and Forecast 2025-2035
Next Generation Sequencing (NGS) Market
The World Health Organization (WHO) continues to emphasize genomic surveillance as an important component of monitoring infectious diseases, while the U.S. National Institutes of Health (NIH) continues to support large-scale genomics programs that advance precision medicine and biomedical research. These initiatives are increasing investments in sequencing platforms, bioinformatics solutions, and genomic testing infrastructure across healthcare and research institutions.
Get Free Sample Report and Related Graphs & Charts @ https://www.emergenresearch.com/request-sample/8
Market Overview
Demand for next generation sequencing continues to increase as sequencing costs decline and analytical capabilities improve. Hospitals, academic institutions, pharmaceutical companies, and biotechnology organizations are integrating sequencing into research and clinical workflows to support oncology testing, rare disease diagnosis, reproductive health screening, and drug discovery. Growing availability of high-throughput sequencing platforms and cloud-based bioinformatics tools is improving laboratory efficiency while enabling larger genomic datasets to be analyzed within shorter timeframes. Expansion of precision medicine programs across developed and emerging healthcare markets is also supporting long-term demand.
Key Growth Drivers
The increasing prevalence of cancer and inherited genetic disorders continues to support wider adoption of sequencing technologies in clinical practice. Pharmaceutical companies are using genomic data to improve biomarker discovery and accelerate development of targeted therapies. Government funding for genomics research and national precision medicine initiatives is expanding laboratory capacity across multiple countries.
Advances in sequencing chemistry, automation, artificial intelligence-assisted data analysis, and cloud computing are reducing turnaround times and improving workflow efficiency. For instance, in September 2024, Illumina, United States, introduced new sequencing innovations designed to improve scalability and support broader adoption of genomic testing across research and clinical laboratories. These are some of the key factors driving revenue growth of the Next Generation Sequencing (NGS) market.
Market Restraints
However, high capital investment required for sequencing instruments and laboratory infrastructure remains a challenge for smaller healthcare facilities and research organizations. Management of large genomic datasets requires specialized bioinformatics expertise and secure data storage capabilities, increasing operational costs.
Regulatory requirements related to clinical validation, patient privacy, and genomic data management also vary across countries, creating additional compliance challenges for laboratories and technology providers. These factors are expected to limit Next Generation Sequencing (NGS) market growth to some extent over the forecast period.
For More Information , Click @ https://www.emergenresearch.com/industry-report/next-generation-sequencing-market
Segment Highlights
The sequencing instruments segment accounted for the largest share of the market due to continued investment by research institutions, clinical laboratories, and pharmaceutical companies in high-throughput sequencing platforms. Demand is supported by increasing use of sequencing in oncology research, rare disease diagnosis, reproductive health testing, and infectious disease surveillance.
The clinical diagnostics segment is expected to register the fastest growth during the forecast period. Hospitals and diagnostic laboratories are expanding the use of genomic sequencing for cancer profiling, companion diagnostics, newborn screening, and inherited disease testing. Growing integration of precision medicine into routine clinical care is supporting adoption across healthcare systems worldwide.
Regional Outlook
North America
North America accounted for the largest share of the global market due to strong investment in biomedical research, advanced healthcare infrastructure, and widespread adoption of precision medicine. The U.S. National Institutes of Health continues to fund large-scale genomics research programs, while companies including Illumina and Thermo Fisher Scientific continue expanding sequencing technologies and laboratory solutions throughout the region.
Europe
Europe represents a major market supported by government-funded genomics initiatives and established clinical research networks. National healthcare systems are increasing the adoption of genomic testing for oncology and rare disease diagnosis. Organizations such as Genomics England continue supporting population-scale sequencing programs that contribute to wider clinical implementation of genomic medicine.
Asia Pacific
Asia Pacific is expected to register the fastest market growth during the forecast period. Governments in China, Japan, South Korea, India, and Singapore are increasing investments in biotechnology research, precision medicine, and genomic healthcare infrastructure. Companies including BGI Genomics continue expanding sequencing capabilities across research and clinical applications. Rising healthcare expenditure, increasing awareness of genetic testing, and expanding biotechnology industries continue to support regional market growth.
The Next Generation Sequencing Market is structured across the following key dimensions:
By Product Outlook (Revenue, USD Million; 2024-2035)
Instruments
Consumables & Reagents
Services & Bioinformatics
By Technology Outlook (Revenue, USD Million; 2024-2035)
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Targeted Sequencing & Resequencing
Transcriptomics / RNA Sequencing
Epigenomics
Others
By Application Outlook (Revenue, USD Million; 2024-2035)
Clinical Diagnostics
Drug Discovery & Development
Academic & Government Research
Consumer Genomics
Others
By End Use Outlook (Revenue, USD Million; 2024-2035)
Hospitals & Clinics
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
Regional Outlook (Revenue, USD Million; 2024-2035)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Request for A Discount On The Report @ https://www.emergenresearch.com/ask-for-discount/8
Contact us:
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee: Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +12092086299
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Sequencing (NGS) Market Size, Share, Trends, Industry Analysis, and Forecast 2025-2035 here
News-ID: 4575666 • Views: …
More Releases from emergen research
In-Vehicle Infotainment (IVI) Market Growth Analysis by Component, Vehicle Type, …
The global In-Vehicle Infotainment (IVI) market, valued at USD 28.14 Billion in 2025, is expected to reach USD 59.62 Billion by 2035, reflecting steady demand for connected mobility technologies across passenger and commercial vehicles. Demand is being supported by rising consumer expectations for seamless digital experiences inside vehicles and the continued adoption of connected car technologies by automotive manufacturers.
Increasing deployment of advanced driver assistance systems (ADAS) is creating demand…
Veterinary Ultrasound Market to Reach USD 1.89 Billion by 2035 at 8.7% CAGR as C …
MARKET SYNOPSIS
The global Veterinary Ultrasound market size was USD 820.4 Million in 2025 and is expected to register a revenue CAGR of 8.7% during the forecast period. Demand for veterinary ultrasound systems is increasing owing to rapid growth in companion animal ownership across North America, Europe, and Asia Pacific, driving pet owners to seek diagnostic imaging services previously limited to human healthcare. Ultrasound systems use piezoelectric transducers to generate real-time…
Aluminum Canisters for Inhalation Aerosols Market to Reach USD 1.31 Billion by 2 …
MARKET SYNOPSIS
The global Aluminum Canisters for Inhalation Aerosols market size was USD 748.6 Million in 2025 and is expected to register a revenue CAGR of 5.7% during the forecast period. Demand for aluminum canisters in metered-dose inhalers is increasing owing to the expanding global burden of asthma and chronic obstructive pulmonary disease, which the World Health Organization estimated affected over 550 million people as of 2024. Aluminum is the primary…
Artificial Intelligence (AI) in Food and Beverage Market to Reach USD 108.77 Bil …
MARKET SYNOPSIS
The global Artificial Intelligence (AI) in Food and Beverage market size was USD 9.65 Billion in 2025 and is expected to register a revenue CAGR of 27.9% during the forecast period. Demand for machine vision and deep learning systems in food processing lines is increasing owing to the cost of product recalls and contamination events that reach retail shelves. Computer vision cameras mounted above conveyor systems flag foreign material…
More Releases for Sequencing
Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period.
Market Outlook:
The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping…
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which…
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Baseclear B.V.
Clinical-Microbiomics A/S
Molzym GmbH & Co. Kg
Zymo Research Corp.
Rancho Biosciences
Microbiome Therapeutics, LLC.
Microbiome Insights Inc.
Openbiome
Resphera Biosciences, LLC.
Ubiome, Inc.
The report covers key developments…
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com
Get Research Sample PDF at https://www.search4research.com/request-sample/113582/
Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,…
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period.
Metagenomics, is a field where genomic analysis of microbial DNA…
